Dabrow Woods, A.Giometti, R.Weeks, S.2015-06-022015-06-022014The JBI Database of Systematic Reviews and Implementation Reports, 2014; 12(1):74-892202-44332202-4433http://hdl.handle.net/2440/91709Review question/objective - In adult intensive care unit patients experiencing alcohol withdrawal, does the use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy decrease delirium severity more effectively than benzodiazepine-based therapy alone? The objective of the systematic review is to examine the best available evidence of the clinical effectiveness of dexmedetomidine as an adjuvant to benzodiazepine-based therapy versus benzodiazepine-based therapy alone, in decreasing delirium severity associated with alcohol withdrawal in adult intensive care unit patients over the age of 18 years.enCopyright status unknownalcohol withdrawal syndrome; benzodiazepine-based therapy; delirium; dexmedetomidine; intensive care unitJournal article003002451810.11124/jbisrir-2014-1285177598